Increased intimal hyperplasia in experimental vein graft stenting compared to arterial stenting: Comparisons in a new rabbit model of stent injury

Cardiovascular Research

Volumn 56, Issue 1, 2002, Pages 164-172

  Alp, Nicholas J ^a   West, Nick E J ^a   Arnold, Nadine ^b   Gunn, Julian ^b   Banning, Adrian P ^a   Channon, Keith M ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b UNIVERSITY OF SHEFFIELD   (United Kingdom)

Author keywords

Coronary disease; Histo(path)ology; Restenosis; Stents; Veins

Indexed keywords

RESIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CAROTID ARTERY; CONTROLLED STUDY; CORONARY STENT; HYPERPLASIA; INTIMA; JUGULAR VEIN; MALE; NONHUMAN; PRIORITY JOURNAL; RABBIT; SMOOTH MUSCLE FIBER; VEIN GRAFT;

ANASTOMOSIS, SURGICAL; ANIMALS; CAROTID ARTERY, COMMON; CORONARY RESTENOSIS; JUGULAR VEINS; MODELS, ANIMAL; RABBITS; STENTS; TUNICA INTIMA;

EID: 0036776060     PISSN: 00086363     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0008-6363(02)00503-5     Document Type: Article

References (13)

1. Channon K.M., Fulton G.J., Shetty G.A., et al. Efficient adenoviral gene transfer to venous bypass grafts: comparison with native vessels. Cardiovasc Res. 35:1997;505-513.
2. Davies M.G., Klyachkin M.L., Dalen H., Svendsen E., Hagen P.-O. Regression of intimal hyperplasia with restoration of endothelium-dependent relaxing factor-mediated relaxation in experimental vein grafts. Surgery. 114:1993;258-271.
3. Davies M.G., Kim J.H., Barber L., Dalen H., Svendsen E., Hagen P.O. Systemic hypertension and hypercholesterolemia in vein grafts: effects on the function and morphology of experimental vein grafts. J Surg Res. 57:1994;106-121.
4. Davies M.G., Klyachkin M.L., Dalen H., Massey M.F., Svendsen E., Hagen P.-O. The integrity of experimental vein graft endothelium-implications on the etiology of early vein graft failure. Eur J Vasc Surg. 7:1993;156-165.
5. O'Donohoe M.K., Schwartz L.B., Radic Z.S., Mikat E.M., McCann R.L., Hagen P.O. Chronic ACE inhibition reduces intimal hyperplasia in experimental vein grafts. Ann Surg. 214:1991;727-732.
6. Huynh T.T., Davies M.G., Trovato M.J., Barber L., Safi H.J., Hagen P.O. Reduction of lipid peroxidation with intraoperative superoxide dismutase treatment decreases intimal hyperplasia in experimental vein grafts. J Surg Res. 84:1999;223-232.
7. Mann M.J., Gibbons G.H., Kernoff R.S., et al. Genetic engineering of vein grafts resistant to atherosclerosis. Proc Natl Acad Sci USA. 92:1995;4502-4506.
8. West N.E.J., Qian H.S., Guzik T.J., et al. Nitric oxide synthase (nNOS) gene transfer modifies venous bypass graft remodeling: effects on vascular smooth muscle cell differentiation and superoxide production. Circulation. 104:2001;1526-1532.
9. Malik N., Gunn J., Holt C.M., et al. Intravascular stents: a new technique for tissue processing for histology, immunohistochemistry, and transmission electron microscopy. Heart. 80:1998;509-516.
10. Hagen P.O., Davies M.G., Schuman R.W., Murray J.J. Reduction of vein graft intimal hyperplasia by ex vivo treatment with desferrioxamine manganese [see comments]. J Vasc Res. 29:1992;405-409.
11. Schulz C., Herrmann R.A., Beilharz C., Pasquantonio J., Alt E. Coronary stent symmetry and vascular injury determine experimental restenosis. Heart. 83:2000;462-467.
12. Miller D.D., Karim M.A., Edwards W.D., Schwartz R.S. Relationship of vascular thrombosis and inflammatory leukocyte infiltration to neointimal growth following porcine coronary artery stent placement. Atherosclerosis. 124:1996;145-155.
13. Garasic J.M., Edelman E.R., Squire J.C., Seifert P., Williams M.S., Rogers C. Stent and artery geometry determine intimal thickening independent of arterial injury. Circulation. 101:2000;812-818.